Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Patient Assistance Program
The Novo Nordisk Patient Assistance Program (PAP) is based on our commitment to our patients. The Patient Assistance Program provides medication at no cost to those who qualify.
Patients who are approved for the PAP may qualify to receive free medication from Novo Nordisk. There is no registration charge or monthly fee for participating.
Click here for a list of our Novo Nordisk products covered by the PAP.
Si habla español, visite nuestra página del programa PAP en español.
Who can participate in the Patient Assistance Program?
To be eligible for this program in 2026, you must:
- Be a US citizen or legal resident
- Have a total household income that qualifies. Visit the NeedyMeds website, which lists the current Federal Poverty Level guidelines
- Have Medicare or no insurance (Note: If you have private or commercial insurance, you are not eligible for the PAP)
- Not be enrolled in or qualify for any other federal, state, or government program such as Medicaid, Medicare Low Income Subsidy (LIS, or Extra Help Program), or Veterans Affairs (VA) Benefits
- If you are eligible for Medicaid or Medicare LIS, you must submit a copy of your denial letter with your application.
For patients on Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg
For patients on Ozempic® pen
- Most Medicare Part D plans cover Ozempic®. Medicare beneficiaries with Part D coverage will no longer be eligible to receive Ozempic® through the Patient Assistance Program.
- Next Steps:
- Plan your spending: You also have the option of spreading your prescription costs throughout the plan year by enrolling in the Medicare Prescription Payment Plan (M3P). To learn more about this program, click here.
- Uninsured patients will still have access to Ozempic® through the Patient Assistance Program; however, their total household income must be at or below 200% of the federal poverty level.
- Resources:
- Visit NeedyMeds website which lists the current FPL guidelines for more information.
For Medicare patients on Novo Nordisk insulins
For Medicare patients on Novo Nordisk insulins
- Total household income must be at or below 400% of the federal poverty level.
- Medicare beneficiaries with a total household income below 150% of the federal poverty level must provide proof of denial for Part D Extra Help to qualify.
- Next Steps:
- For more information on how to apply for the Extra Help Program, please click here. If you will be a Medicare patient in 2026 and meet eligibility requirements for PAP, please download the application in English or Spanish to apply.
- Novo Nordisk has other programs to help make insulin affordable. Explore your options.
- Medicare resources designed for you
For uninsured patients on all products
For uninsured patients on all products
- Total household income must be at or below 200% of the federal poverty level for Ozempic. For all other medications, total household income must be at or below 400% of the federal poverty level.
- Uninsured patients must provide proof of a Medicaid denial prior to enrollment in the PAP if the patient’s total household income meets their state federal poverty limit thresholds. For more information about your state’s Medicaid program, you can click here. You can also visit the NeedyMeds website which lists the current FPL guidelines for more information.
- Next Steps:
- For uninsured insulin patients, Novo Nordisk has other programs to help make insulin more affordable. Click here for insulin affordability options.
A special note about your medicine
Some medicines will no longer be a part of the Patient Assistance Program for 2026. Please click here to see a list of Novo Nordisk medicines that are still covered by the program.
Apply for the PAP
Please complete your part of this form.
Si habla español, visite nuestra página del programa PAP en español.
Questions? See the frequently asked questions below or call Novo Nordisk toll-free at 1‑866‑310‑7549.
Apply by paper application
Applications are available in English and Spanish.
También puede visitar nuestra página del programa PAP en español.
STEP 1: Download and fill out the application
Complete the following sections:
- Patient Information Section
- Insurance
- Medicare Part D consent (if applicable)
- All consents
STEP 2: Proof of income
For your convenience, Novo Nordisk will verify your income electronically.
STEP 3: Ask your health care provider to complete the application
Take your application to your health care provider and have them:
- Complete the Prescriber and Rx sections of the application
- Sign and date the application
- Fax the completed application to 1‑866‑441‑4190, or mail them to Novo Nordisk Inc., PO Box 370, Somerville, NJ 08876. Faxes must be sent from your health care provider's office
Please allow up to 10 business days for the processing and outcome.
Note: After the application is reviewed, you and your health care provider will be informed of the decision. If approved, your medicine will be sent to your health care provider’s office, where you can pick it up.
Product availability subject to change without notice.
Novo Nordisk reserves the right to modify or cancel this program at any time without notice.
Important
Do not include patient medical records with this application
- Patients who are eligible for Medicaid or Medicare LIS must submit a copy of their denial letter with their application
- Qualified Medicare patients will be enrolled in the program through December 31st of the calendar year
Enrollment details
If approved, how long am I enrolled in the program?
Uninsured patients are enrolled for 12 months. Medicare patients are enrolled for a calendar year.
I have Medicare Part D coverage. Do I need to spend $1000 in out-of-pocket prescription costs before I am able to apply to the program?
No, we no longer require that Medicare Part D patients spend $1000 out-of-pocket to be eligible for the program.
Application process and approval
How long does it take to process an application?
If an application is submitted with all supporting documentation and all required fields completed, it will be processed within 2 business days. Any missing or incomplete information may cause a delay.
How will I know if I have been approved?
If approved, patients will receive a letter in the mail. Also, if a patient opts in for automated phone notification on the application, they will receive an automated recorded phone message notification.
Health care providers will receive a letter via fax.
If I have been approved, how long does it take to receive my medication?
Once approved, a patient's medication should arrive at their prescriber's office within 10-14 business days.
Medication shipment
Can you ship my medication directly to my home?
Unfortunately, we are currently not able to ship directly to patients.
Can you ship my medication directly to a local pharmacy?
Unfortunately, we are currently not able to ship directly to a pharmacy.
Change of doctor or address
What should I do if I have switched doctors?
Please contact us at 1-866-310-7549 so we can provide additional direction.
What should I do if I have moved?
Please contact us at 1-866-310-7549 so we can update your records.
What should I do if my doctor has moved?
Please contact us at 1-866-310-7549 so we can update your records.
PAP reapplication
Do I have to reapply to the program when my enrollment ends?
Yes. Patients will need to submit a new application and supporting documentation when their enrollment ends if they'd like to be considered for continued support.
If my enrollment is ending, how soon can I reapply to the program?
Patients may submit a new application 30 days prior to the end of their enrollment. Medicare Part D patients may apply after October 15th of the current year to enroll for the following year.
Program information
Medicare Part D
Those with Medicare Part D coverage may apply for next year’s PAP enrollment after October 15, 2026.
Auto refill
The Novo Nordisk PAP now offers automatic refills for most medications.
All new applicants will be automatically enrolled. The medication will be shipped to the prescriber of an approved enrollee/applicant in accordance with current program guidelines. Auto refills terminate at the end of the patient’s program enrollment period. Auto refills are managed by the prescriber.
Please note: Not all medications are eligible for auto refill. Please view full list of excluded products.
Find helpful resources
Need help navigating insurance?
We can make health insurance easier to understand. From copays to deductibles, we explain common terms and tell you how health insurance works. You’ll also see tips to get the most out of your plan, or find a new one.
Resources and education
Find inspiration and motivation for staying active, eating healthy, and building up your knowledge with resources and education from NovoCare®.